Regnante Keith's Form 4/A amendment
AmendedKeros Therapeutics, Inc. (KROS) · filed Jan 24, 2025
- Accession no.
- 0001415889-25-002024
- Filed
- Jan 24, 2025
- Trade date
- Jan 4, 2024
- Filing delay
- 386 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jan 8, 2024
This filing lists 2 non-derivative transactions. It carries over 1 transaction from the original filing that it did not restate. Open-market sales total $1.81M. It was filed 386 days after the trade.
This amendment restates part of 0001209191-24-001155 (filed Jan 8, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Regnante KeithCIK 0001682068 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | MOption exerciseAcquired | +40,000 | $16.00 | +$640,000 | 40,000 | Direct | |
| Jan 4, 2024 | Common Stock | SSaleDisposed | −40,000 | $45.29 | −$1,811,600 | 0 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-24-001155 (filed Jan 8, 2024).
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 53,622 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amendment is being filed to correct the Date of Earliest Transaction and the Transaction Date of each transaction listed in Table I.
- F2
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 8, 2023.